Aims and objectives
The detection rate of Pancreatic cystic neoplasms (PCNs) as incidental finding has shown a continuous increase in the last decade,
in particular in the elderly population.
this is to be accounted more to the extensive use of cross-sectional imaging than to an effective increase of incidence in the general population .
Among the cystic lesions of the pancreas,
intraductal papillary mucinous neoplasia (IPMN) is one of the most frequent .
IPMNsare characterized by intraductal proliferation of neoplastic mucinous cells with consequent cystic dilation of...
Methods and materials
Inclusion criteria: patients with EUS or pathological diagnosis of IPMN who underwent an MRI examination between July 2015 and December 2017 at Department of Radiology of University Hospital of Ancona,
Exclusion criteria: lack of MRI examination,
contraindication to contrast media administration and lack of EUS,
pathological and clinical data.
MRI studies were performed with a 1.5-T scanner (GE Signa HdXt,
WI) and an eight-channel phased-array body coil.
The examination protocol included axial and coronal fast spin-echo (FSE) T2-weighted sequences,...
A total of 33 patients were included (13 male,
21 female) with mean age 67 (range 43-82 y.o.) with an average of 2.1 of cystic lesions >5mm per patient and an average of cystic diameter of 15.2 mm.
Table 1 shows demographics and evaluation of WF and HRS by reader A.
Figure 2 shows IRA between the three readers for the WF and HRS with ICC values included between 0.623 and 0.905.
No significant differences between ICC were detected due to 95%CI overlap ( Fig....
The Fukuoka Guidelines for IPMN allowed for a reproducible evaluation of WF and HRS with moderate to good IRA in readers with different experience.
Association Between Advances in High-Resolution Cross-Section Imaging Technologies and Increase in Prevalence of Pancreatic Cysts From 2005 to 2014,
Clinical Gastroenterology and Hepatology.
Pancreatic cysts: pathologic classification,
and clinical implications,
133 (2009) 423–438.
Revisions of international consensus Fukuoka guidelines for the management of IPMN...